Rincon Bio performs LNCaP xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
DU-LNCaP cells were derived from 50 year old male Caucasian with carcinoma
Genes expressed: human prostatic acid phosphatase; prostate specific antigen
Receptor Expression: androgen receptor, positive; estrogen receptor, positive
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: LNCaP
Mouse Strain: Nod-Scid Gamma from Jackson, Male
Animals per Group: 5
Positive Control: None
Dosing schedule: N/A
Cells Implanted per Animal: 5.5 million
Stratification size: N/A
Days from implant to stratification: N/A
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.